BAR HARBOR — The role of next-generation therapies in cancer treatment will be the subject of a March 11 MDI Science Cafe titled “The Frontiers of Cancer Research” by cancer biologist/immunologist Muneer G. Hasham, Ph.D.
The cafe, which is offered through the MDI Biological Laboratory, will be held at 5 p.m. Monday, March 11, at the Maine Center for Biomedical Innovation on the campus of the MDI Biological Laboratory at 159 Old Bar Harbor Road in Bar Harbor.
In his talk, Hasham will draw on his research on new cancer therapies at The Jackson Laboratory in Bar Harbor, where he is study director of the patient derived xenograft program and has his own cancer research program. His research interests include immune disorders and cancer pathogenesis and therapeutics.
Though most people are familiar with traditional cancer treatments such as surgery, radiation and chemotherapy, many aren’t as familiar with the next-generation cancer therapies that will be the subject of Hasham’s talk, including immunotherapy, genetically targeted chemotherapy, oncolytic virus therapy and combination therapy.
Because they target cancer cells more precisely, these therapies are better tolerated by patients and lead to improved outcomes.